News

January, 2016

Prodo Laboratories has moved into a new research building, expanding its operations and capabilities in the diabetes research community.

read more

December, 2015

Prodo Islet Media is now being shipped globally and is the preferred solution for islet culturing.

read more

May, 2015

Prodo Labs continues to globally ship human islets on a weekly basis, with over 60 million IEQ sent to academic and corporate investigators in over 30 countries.

read more

March 7th, 2012

The Food and Drug Administration has granted Prodo Laboratories, Inc. a Biological Master File number for the Prodo Islet Media (PIM)®!  The BMF number is IND-15016.  Clinical testing is approved and underway at several isolation centers.

read more

November 2, 2011

Transplantation Center testing confirms that Prodo Islet Media out performs CRML based media by a considerable margin. Worldwide testing is underway at additional centers.

read more

June 1, 2011

Prodo Labs officially launched their cGMP Islet Culture Media (Prodo Islet Media-PIM) at the International Pancreas and Islet Transplant Association meeting in Prague. Please visit our cGMP Products section for more information.

read more

February 14, 2011

Prodo Labs has now shipped over 16 million islets to both the corporate and academic communities, with purity averaging 85-90% and viability averaging 95%.

read more

November 5, 2010

Prodo Labs announces being the recipient of two new grants from the Qualifying Therapeutic Discovery Grant (QTDG) funds from a combined NIH/IRS program to provide stimulus funds to small businesses working to develop new health care products. The first grant is for...

read more

October 1, 2010

Prodo Labs announces its ability to begin supplying human islets from Type 2 Diabetes research pancreas donors directly to corporate and academic investigators. There is a need for supplying human islets processed from Type 2 Diabetes pancreases. These are obtained...

read more

July 1, 2010

Prodo Labs publishes a new article in Transplantation Proceedings regarding its success in processing large quantities of human islets from research pancreas donors with long cold ischemia times. Prodo Labs has published its most recent results of processing and...

read more

April 21, 2010

Prodo Labs and the Scharp-Lacy Research Institute collaborate to increase the numbers of high quality human islets for distribution through a new contract with the National Institute for Diabetes, Digestive, and Kidney Diseases (NIDDK) of the National Institutes of...

read more

October 15, 2009

Prodo Labs announces cut back in activities due to reduced islet orders from the economic turndown. With slow down in the economy, major corporate pharmaceutical companies are changing their priorities in their research operations and reducing the number of human...

read more

March 18, 2009

Prodo Labs presented at the Rochmeil Levine Symposium A paper entitled, "USE OF ROCHE cGMP LIBERASE® MTF C/T IN ISLET ISOLATION FROM HUMAN PANCREAS WITH EXTENDED COLD ISCHEMIA TIME (CIT), was presented at the City of Hope annual Levine Symposium. It demonstrated the...

read more

July 1, 2008

Prodo Labs announces that its contracts for the distribution of human islets for research have reached pharmaceutical companies with a total annual R&D budget of $26 Billion. Prodo Labs provides human islets for research to biotechnology and pharmaceutical...

read more

June 23, 2008

The Scharp –Lacy Institute replaces the Invenio Institute and takes control of its contract with the JDRF to supply human islets for research to its funded investigators. Invenio Institute has decided to change its name to The Scharp-Lacy Research Institute to capture...

read more

April, 2008

Invenio Institute Awarded Contract by Juvenile Diabetes Research Foundation (JDRF) to Distribute Human Islets for Research to Their Funded Investigators. The JDRF has renewed a contract with Invenio Institute to distribute human islets which had distributed 5 million...

read more

September 16, 2007

Prodo Laboratories, Inc. launches two new products at the International Pancreas and Islet Transplant Association (IPITA) Conference in Minneapolis. Prodo Labs is launching two new tissue culture products specifically designed for islets at the international IPITA...

read more

July 15, 2007

Prodo Labs Announces Acceptance of Small Business Administration Loan. Prodo Laboratories, Inc is pleased to announce that its application to the U.S. Small Business Administration (SBA) has been accepted with a loan from Plaza Bank, Irvine, CA for $300,000 to...

read more

July 5, 2007

Prodo Laboratories, Inc. begins processing human pancreases. Prodo Labs begins operations today by processing its first human pancreas into viable human islets to be sent to diabetes researchers to assist their efforts to help patients with diabetes. After many months...

read more

June 1, 2007

Invenio Institute receives contract from Juvenile Diabetes Research Foundation to provide human islets for JDRF and NIH diabetes researchers. Invenio Institute was awarded a research contract to distribute human islets for research to academic investigators needing...

read more

November 16, 2006

Prodo Laboratories Inc. and Invenio Insitute are announced at the Rachmiel Levine Diabetes and Obesity Symposium. Irvine, Ca. Two new diabetes companies, Prodo Laboratories, Inc. and Invenio Institute, announced their launch at the Rachmiel Levine Diabetes and Obesity...

read more

November 1, 2006

Prodo Laboratories, Inc and Invenio Institute rent office space. Prodo Laboratories and Invenio Institute have rented a two story 8,100 sq ft office suite with warehouse at 32A Mauchly, Irvine, CA 92618 to be developed into a research and development facility....

read more

September 19, 2006

Invenio Institute founded. Invenio Institute has been founded as a California public benefit company to function as a not-for-profit research institute to perform diabetes research that will lead to new products for patients with diabetes

read more

September 11, 2006

Prodo Laboratories, Inc. founded. Prodo Laboratories, Inc was founded today founded as a Delaware corporation intending to operate as a for-profit diabetes biotechnology company to develop products for diabetes researchers and for patients with...

read more